Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis

Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis

Abstract Background Patients with lung cancer who are treated with carboplatin-based chemotherapy regimens often experience chemotherapy-induced nausea and vomiting (CINV). However, knowledge on the effect of regimen and cofactors on the risk of CINV is limited. This study aimed to analyze and compa...

Full description

Bibliographic Details
Main Authors: Toshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo, Hirotoshi Iihara, Kei Kawada, Takafumi Nakano, Takashi Egawa
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Cancer
Subjects:
Antiemetics
Chemotherapy-induced nausea and vomiting
Emetogenicity
Lung cancer
Classification
Carboplatin
Online Access:https://doi.org/10.1186/s12885-021-07802-y

Internet

https://doi.org/10.1186/s12885-021-07802-y

Similar Items